24 May 2013
Keywords: proposals, medicare, prescription, drug, plan, pfizer, ceo
Article | 04 April 2000
In the national debate over pharmaceutical coverage for US Medicarebeneficiaries, consensus is emerging on one point - the near-poor
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 April 2000
3 April 2000
23 May 2013
© 2013 thepharmaletter.com